NasdaqHealth CarePharmaceutical PreparationsREHOVOT, Israel

Purple Biotech Ltd. PPBT

Ask your AI

A stock split around the filing date makes the share count unclearCIK 1614744

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

4 added · 1 trimmed

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

What changed in Purple Biotech Ltd.'s latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

91,618 shares

11 funds report PPBT. Values checked against market prices.

Q3 2026. 3 new, 4 added to, 1 trimmed, 5 exited since Q2 2026.

Top 13F holders
#
1	SmartHarvest Portfolios, LLC 13F ↗	51,267	$77.9K	+80.1%
2	HRT Financial LP 13F ↗	18,229	$27.0K	n/a
3	Jane Street Group, LLC 13F ↗	14,003	$21.3K	New
4	UBS Group AG 13F ↗	6,472	$9,837	+761.8%
5	Rhumbline Advisers 13F ↗	850	$1,291	-0.7%
6	BNP Paribas Financial Markets 13F ↗	400	$608	New
7	Morgan Stanley 13F ↗	300	$456	+52.3%
8	Caitong International Asset Management Co., Ltd 13F ↗	78	$119	New
9	Northwestern Mutual Wealth Management Co 13F ↗	8	$12	unchanged
10	IFG Advisory, LLC 13F ↗	7	$11	unchanged

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds PPBT, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Purple Biotech Ltd. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Purple Biotech Ltd. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2026	15	—	75,666	$305.6K
Q2 2026	13	-2	84,425	$141.0K
Q3 2026	11	-2	91,618	$138.6K

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (74638P307). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes5 in 12 mo 8-K eventsNone in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record FDA decisionsLatest Apr 28 IPO history7 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: PURPLE BIOTECH LTD.
Address: 4 OPPENHEIMER STREET, SCIENCE PARK, REHOVOT, Israel 7670104
Phone: 97239333121
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer
Incorporated in: Israel
Listed as: PPBT (Nasdaq)
Former names: Kitov Pharma Ltd. (until 2020); Kitov Pharmaceuticals Holdings Ltd. (until 2017)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.63+$0.07 (+4.49%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.924 · High $1.63Nov 13, 2026

Aug 13, 2026Low $0.924 · High $1.98Nov 13, 2026

Nov 13, 2025Low $0.924 · High $8.74Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-10 on Mar 2, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.